Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Presentation

<< Previous

Bullboard Posts

Next >>

Comment by Sailboatdreamon Apr 08, 2021 6:29pm

154 Views

Post# 32963868

RE:RE:RE:RE:Presentation

Redbaron2211 wrote: Ms Sally for all we know there might not be an AGM this year. I don't get the frustration and impatience around the licensing deal. With NDAs the answers are obviously not going to come to us. If some one doesn't think Philip can pull it off then best strategy would be to sell. Otherwise it's a waiting game.

to my knowledge, AGM's are mandatory in Canada for public companies. Also, I would disagree that "waiting game", lack of information, lack of progress on commitments (I.e. completing diabetes trials cohort in Q1) and inability to properly capitalize on the amazing results published in Jan is a valid investment strategy.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages